COMMUNIQUÉS West-GlobeNewswire
-
Smart for Life Provides Update Following Nasdaq Delisting Due to Audit Delays; Reports Plans to Reapply to Nasdaq Upon Full Compliance
20/09/2024 -
Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/09/2024 -
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
20/09/2024 -
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20/09/2024 -
ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
20/09/2024 -
L’Arche Vancouver opens new $37-Million Dream Home
20/09/2024 -
Wounded Warriors Family Support Provides Veterans with Program Toward Financial Competency, Independence
20/09/2024 -
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
20/09/2024 -
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
20/09/2024 -
Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
20/09/2024 -
Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs
20/09/2024 -
ChemoMetec makes offer to buy Ovizio Imaging Systems SA
20/09/2024 -
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
20/09/2024 -
Range Impact Announces Application to Uplist to the OTCQB Venture Market
20/09/2024 -
Koelis Announces Partnership and Initial Experience with DeepHealth for AI-powered Prostate MRI Interpretation and Guidance in Fusion Biopsy
20/09/2024 -
Altamira Therapeutics to Host First Half 2024 Financial Results and Business Update Call on September 24, 2024
20/09/2024 -
MESMERIZE brings community pharmacy leaders together to explore industry’s bright future
20/09/2024 -
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
20/09/2024 -
T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union
20/09/2024
Pages